Lottie H. Shackelford is Director at MEDICIS PHARMACEUTICAL CORP (MRX). They have made 5 open-market trades across 1 company since 2006, most recently 2012-12-11.
CIK 0001257563
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| MRX | 30,422 | $2.1M |
Shares reported on the most recent Form 4, priced at the 2012-08-28 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MRX | SELL | 2012-08-24 | 2012-08-28 | $32.53 | $651K | +2.8% | +2.3% | +2.3% |
| MRX | SELL | 2011-05-26 | 2011-05-27 | $36.82 | $736K | +2.8% | +2.3% | +2.3% |
| MRX | SELL | 2009-08-31 | 2009-09-02 | $18.04 | $541K | +2.8% | +2.3% | +2.3% |
| MRX | SELL | 2008-05-30 | 2008-06-02 | $23.70 | $284K | +2.8% | +2.3% | +2.3% |
| MRX | SELL | 2006-05-15 | 2006-05-17 | $31.91 | $892K | +2.8% | +2.3% | +2.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.